Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diane K Wysowski

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Bone|November 21, 2013
Reply to: effect of pharmacological treatment of osteoporosis in the prevention of pathological vertebral fracturesDiane K Wysowski
Drug Safety|June 1, 2007
Surveillance of prescription drug-related mortality using death certificate dataDiane K Wysowski
Public Health Reports (Washington, D.C. : 1974)|July 11, 2006
Increase in deaths related to enterocolitis due to Clostridium difficile in the United States, 1999-2002Diane K Wysowski
BMJ (Clinical Research Ed.)|September 4, 2010
Oral bisphosphonates and oesophageal cancerDiane K Wysowski
The New England Journal of Medicine|January 2, 2009
Reports of esophageal cancer with oral bisphosphonate useDiane K Wysowski
The Journal of Allergy and Clinical Immunology|July 12, 2002
Use of inhalant medications with and without chlorofluorocarbon propellants in the United States, 1996-2000Diane K Wysowski, Joslyn Swann
The Journal of Urology|February 11, 2003
Use of medications for erectile dysfunction in the United States, 1996 through 2001Diane K Wysowski, Joslyn Swann
Archives of Internal Medicine|June 29, 2005
Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactionsDiane K Wysowski, Lynette Swartz
Bone|September 26, 2013
Trends in osteoporosis treatment with oral and intravenous bisphosphonates in the United States, 2002-2012Diane K Wysowski, Patty Greene
Public Health Reports (Washington, D.C. : 1974)|October 27, 2004
Analyzing prescription drugs as causes of death on death certificatesDiane K Wysowski, Parivash Nourjah
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Bone|November 21, 2013
Reply to: effect of pharmacological treatment of osteoporosis in the prevention of pathological vertebral fracturesDiane K Wysowski
Drug Safety|June 1, 2007
Surveillance of prescription drug-related mortality using death certificate dataDiane K Wysowski
Public Health Reports (Washington, D.C. : 1974)|July 11, 2006
Increase in deaths related to enterocolitis due to Clostridium difficile in the United States, 1999-2002Diane K Wysowski
BMJ (Clinical Research Ed.)|September 4, 2010
Oral bisphosphonates and oesophageal cancerDiane K Wysowski
The New England Journal of Medicine|January 2, 2009
Reports of esophageal cancer with oral bisphosphonate useDiane K Wysowski
The Journal of Allergy and Clinical Immunology|July 12, 2002
Use of inhalant medications with and without chlorofluorocarbon propellants in the United States, 1996-2000Diane K Wysowski, Joslyn Swann
The Journal of Urology|February 11, 2003
Use of medications for erectile dysfunction in the United States, 1996 through 2001Diane K Wysowski, Joslyn Swann
Archives of Internal Medicine|June 29, 2005
Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactionsDiane K Wysowski, Lynette Swartz
Bone|September 26, 2013
Trends in osteoporosis treatment with oral and intravenous bisphosphonates in the United States, 2002-2012Diane K Wysowski, Patty Greene
Public Health Reports (Washington, D.C. : 1974)|October 27, 2004
Analyzing prescription drugs as causes of death on death certificatesDiane K Wysowski, Parivash Nourjah
Pageof 3